chrX-1290412-G-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_172245.4(CSF2RA):ā€‹c.549G>Cā€‹(p.Leu183=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00048 in 1,613,696 control chromosomes in the GnomAD database, including 1 homozygotes. There are 322 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Synonymous variant affecting the same amino acid position (i.e. L183L) has been classified as Benign.

Frequency

Genomes: š‘“ 0.0027 ( 1 hom., 176 hem., cov: 32)
Exomes š‘“: 0.00025 ( 0 hom. 146 hem. )

Consequence

CSF2RA
NM_172245.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.887
Variant links:
Genes affected
CSF2RA (HGNC:2435): (colony stimulating factor 2 receptor subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. The encoded protein is a member of the cytokine family of receptors. This gene is found in the pseudoautosomal region (PAR) of the X and Y chromosomes. Multiple transcript variants encoding different isoforms have been found for this gene, with some of the isoforms being membrane-bound and others being soluble. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant X-1290412-G-C is Benign according to our data. Variant chrX-1290412-G-C is described in ClinVar as [Benign]. Clinvar id is 226542.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.887 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00267 (407/152216) while in subpopulation AFR AF= 0.00929 (386/41538). AF 95% confidence interval is 0.00853. There are 1 homozygotes in gnomad4. There are 176 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 176 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CSF2RANM_172245.4 linkuse as main transcriptc.549G>C p.Leu183= synonymous_variant 7/13 ENST00000381529.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CSF2RAENST00000381529.9 linkuse as main transcriptc.549G>C p.Leu183= synonymous_variant 7/131 NM_172245.4 A2P15509-1

Frequencies

GnomAD3 genomes
AF:
0.00266
AC:
405
AN:
152098
Hom.:
1
Cov.:
32
AF XY:
0.00234
AC XY:
174
AN XY:
74292
show subpopulations
Gnomad AFR
AF:
0.00927
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000985
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.000721
AC:
181
AN:
251178
Hom.:
0
AF XY:
0.000597
AC XY:
81
AN XY:
135742
show subpopulations
Gnomad AFR exome
AF:
0.00960
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000252
AC:
368
AN:
1461480
Hom.:
0
Cov.:
32
AF XY:
0.000201
AC XY:
146
AN XY:
727046
show subpopulations
Gnomad4 AFR exome
AF:
0.00872
Gnomad4 AMR exome
AF:
0.000783
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.00e-7
Gnomad4 OTH exome
AF:
0.000613
GnomAD4 genome
AF:
0.00267
AC:
407
AN:
152216
Hom.:
1
Cov.:
32
AF XY:
0.00236
AC XY:
176
AN XY:
74420
show subpopulations
Gnomad4 AFR
AF:
0.00929
Gnomad4 AMR
AF:
0.000984
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.000947
Bravo
AF:
0.00296

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Leu183Leu in exon 8 of CSF2RA: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.7% (32/4406) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs139093878). -
Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 12, 2024- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.087
DANN
Benign
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139093878; hg19: chrX-1409305; API